GLP-1s were associated with lower risk of new substance use disorder diagnoses Across alcohol, cannabis, cocaine, nicotine, opioids, and other drug categories, people who started a GLP-1 medication were less likely to receive a new substance use disorder diagnosis over the following 3 years relative to those who started the comparison diabetes medication, sodium-glucose cotransporter-2 inhibitor
This is attributed to DSIPs ability to regulate the bodys stress response and induce relaxation, which can help alleviate withdrawal symptoms
doi: 10.1016/S0140-6736(10)60307-8 34 NauckMFridAHermansenKShahNSTankovaTMithaIHet al
Transform Your Weight Loss Journey with Ageless Center At Ageless Center, we dont just offer GLP-1 medicationswe provide a comprehensive, medically supervised program designed to help you achieve lasting success
Injection technique considerations : Proper subcutaneous injection technique ensures optimal administration